Creative Biogene Provides One-stop PEM-Seq Service to Assess Off-target Effect of CRISPR/Cas9

MIB Agents Now Accepting Applications for Annual OutSmarting Osteosarcoma Research Grants

Majority of “Chronic Coughers” are 55+ and Cough Over 450 Times Per Day, New Exclusive Data from Hyfe AI Finds

Insights from over 4,000 consumer cough-tracking app users sheds light on those struggling with chronic cough and key characteristics of the condition that needs greater awareness and more treatment options.

Phastar Offers Pro Bono Support to Medicines Development for Global Health

Phastar Offers Pro Bono Support to Medicines Development for Global Health Supporting medicine development for disadvantaged communities

Quotient Sciences Announces Major Investment in Sterile Fill/Finish Capacity in Response to Increasing Industry Demand

Creative Bioarray Revolutionizes Biopharma Research with Comprehensive iPSC Characterization Techniques

Alfa Chemistry’s Elemental, Ions and Water (Karl Fischer) Standards Make Analytical Testing More Accurate and Easier

Vizgen Announces MERSCOPE® Platform Grant Program Winners

Vizgen announced the winners of its first MERSCOPE® Platform Grant Program. Open to researchers in Europe and North America, the grants were awarded to the researchers with the most innovative and impactful proposals in cancer research. Vizgen created the grant program to expand the reach of spatial genomics as an essential tool for academic research and the life science industry. Grant winners Aveline Filliol, PhD, Lead Program Manager in the Scott Lowe’s lab at Memorial Sloan Kettering Cancer Center (MSK), and Marek Piprek, MD, PhD candidate, at the Chris Marine Lab at the VIB-KU Leuven Center for Cancer Biology in Leuven, Flemish Region, Belgium will receive a full Vizgen® Lab Services MERFISH study generated on the MERSCOPE Platform.

Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics

Ventric Health Receives FDA 510(k) Clearance for Vivio®

Ventric Health Receives FDA 510(k) Clearance for Vivio®

New expert advisory board appointments set to drive growth and innovation at Hongene

One of the world’s leading biotech companies Hongene has announced the creation of an expert advisory panel with leading international experts to drive forward their growth agenda and science-led innovation

Samsung Biologics reports third quarter 2023 financial results

Incheon, S. Korea, October 25, 2023 – Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the third quarter of fiscal year 2023.

New Threat Actors Drive Record Levels of Ransomware Attacks in September

A new research report from cybersecurity consulting firm, NCC Group finds healthcare experienced an 86% increase in ransomware attacks in September over August. Overall, there was a record high number of ransomware attacks launched by cybercriminals in September, with 514 victims -- a 153% year-on-year rise from September, 2022. This increase was accompanied by the emergence of new threat actors, such as LostTrust and RansomedVC, who became some of the most active groups.

1upHealth Joins Early Adopter Program for NCQA Digital Content Services

Proscia Achieves ISO 27001 Security Certification

Compliance with global information security management standard strengthens customer trust

Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox

Creative Biostructure Announces Comprehensive Exosome Analysis Services

Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach

CD BioGlyco Releases One-Stop Services for Glycoprotein-Based Vaccine Development

Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies